Max Application has developed a Business Intelligence module for pharmaceutical companies, designed to facilitate the collection, analysis, and exploration of data on adverse drug events. The platform provides intuitive dashboards, drill-down tools, and customizable KPIs, allowing clear data visualization and supporting the identification of relevant signals for assessing the risk-benefit profile of pharmaceutical products.
case-studies
Business Intelligence for Pharmacovigilance
Approach and methodology
The project involved the development of a Business Intelligence module dedicated to pharmacovigilance, designed with an emphasis on simplicity, flexibility, and customization. The platform provides intuitive dashboards, advanced drill-down tools, and customizable visualizations, allowing users to explore adverse event data in detail. Through dedicated KPIs and advanced analytical tools, the module enables the rapid identification of potential risk signals, supporting timely and informed decision-making. The solution is designed to adapt to the specific needs of each pharmaceutical company, facilitating the management of complex data and ensuring regulatory compliance, operational efficiency, and accuracy in evaluating the risk-benefit profile of drugs.
The Business Intelligence module was developed with a strong focus on simplicity, flexibility, and customization. Thanks to intuitive dashboards and advanced analytical tools, it allows users to explore adverse event data with drilldowns, personalized visualizations, and KPIs to effectively facilitate signal detection.
Staff involved in the project
2
Specialists
Execution time
1
Years
Technologies used
- Analisi dei dati
- B.I.
80
%
Analysis of aggregated pharmacovigilance data
100
%
Disproportionality analysis for signal detection
Get in touch with
Abacus Group
Contact Us
Thank you for providing the required information below, marked with an asterisk (*). This will help us provide you with the best possible response.